Table 4. Early and sustained induction of TLO associated genes in allografts from latently infected donors.

Shown are fold change values compared to uninfected non-transplanted hearts (n=3 for each time point).

	Latently Infected Donor (LDI)					Uninfected Control
POD	7	14	21	28	35	7	14	21	28	35
CCL19	4.5*	6.6	14.8	17.4	11.8	1.6	2.7	7.8	10.2	7.8
CCL21	1.4	2.1	3.1*	2.2*	1.0	1.2	1.4	1.1	0.7	0.8
CXCL13	9.0*	10.0	11.9	13.2	13.8	3.2	7.1	4.9	9.8	11.8
ICAM-1	3.9*	3.7	4.5	5.9	5.2	1.3	3.1	2.7	3.1	5.6
MADCAM1	1.1*	2.0	1.3	3.0	1.7	0.8	1.2	0.8	0.9	0.9
VCAM-1	3.6*	4.9	6.0	7.7	7.7	1.7	4.4	3.2	5.0	6.8
Lymphotoxin A	0.7	0.6	1.0	1.2	0.9	0.6	0.5	0.7	0.9	0.9
Lymphotoxin B	4.5*	3.8*	6.4	10.7*	11.4	2.0	2.2	3.1	6.4	12.2

^*{p<0.05 infected vs. uninfected}